Skip to main content

BIMZELX®▼ SmPC

Adverse Events

UCBCares for Immunology
UCBCares for Immunology
  • MOA
  • Efficacy & Safety
    • HS
    • PSO
    • PsA
    • AS and Nr-axSpA
  • Latest congress data
Welcome to the Bimzelx.eu website
  • Create a new account
  • Login

Log in to your account

Welcome back. Please enter your details.

Access is denied

Sorry, the page you are trying to access requires an account. Please log in to continue.
Forgot password?

Don’t have an account? Create your account now!

 

Are you a healthcare professional?

This website is intended for healthcare professionals in Europe (excluding the United Kingdom). Please confirm you are a healthcare professional before entering this website.

Dermatologist Rheumatologist Other HCP Not an HCP

Consider creating a UCB account for full access or login to your existing account.

 

 

You are now leaving this website.

You are now leaving the Bimzelx-eu website and are about to enter another website. UCB is not responsible for the content of the website you are about to enter.

Cancel Continue
 
 
 
Image
UCBCares for Immunology
Sitemap

You are here:

You are here

  2. Log in
Homepage Privacy Policy Terms and Conditions Cookie Policy Cookie Preferences Contact us

▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare Professionals are asked to report any suspected adverse reactions.

 

This educational website is published by UCB Biopharma SRL and is intended for practicing healthcare professionals in the European Union (excluding the UK) interested in the field of immuno-mediated inflammatory conditions and their treatment with BIMZELX®. Terms and conditions apply.

 

This website is not intended to be used for reporting adverse events related to UCB’s products. However, if you have any adverse events to report, then please follow the current regulatory procedure in force in your country or visit the contact page of the UCB corporate website where you can report adverse events to UCB local affiliate contacts or UCBCares®.

 

EU-BK-2500043 Date of preparation: May 2025

 

Updated: 2 May 2025

Image
UCB

© UCB Biopharma SRL, 2026. All rights reserved.